Editorial: Signaling pathways behind immune evasion and therapy resistance
Front Immunol
.
2022 Dec 9:13:1104167.
doi: 10.3389/fimmu.2022.1104167.
eCollection 2022.
Authors
Elena Martin-Orozco
1
,
Lisheng Wang
2
,
Shilpak Chatterjee
3
,
Brent A Hanks
4
Affiliations
1
Murcia BioHealth Research Institute, University of Murcia, Murcia, Spain.
2
Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, Canada.
3
Indian Institute of Chemical Biology (CSIR), Kolkata, India.
4
Department of Medicine, Duke University, Durham, NC, United States.
PMID:
36569846
PMCID:
PMC9780664
DOI:
10.3389/fimmu.2022.1104167
No abstract available
Keywords:
N6-methyladenosine; PD-L1; PDE4B; PDIA5; UPR; UQCRC1; cAMP; tumor immunity.
Publication types
Editorial
MeSH terms
Biochemical Phenomena*
Cell Line, Tumor
Immune Evasion*
Signal Transduction